Customized Vaccination Programs

Tailoring a plan to each business’s context & needs

Designing a suitable vaccination program is a complicated undertaking, requiring both avian veterinary expertise and a deep understanding of poultry business goals. For example, for optimal health and performance a production broiler chicken may require10 or more vaccines in just 40 or so days of life under extreme conditions.

That’s where Boehringer Ingelheim’s Veterinary Services group steps in. Working closely with customers’ own veterinary staff, these specialized avian veterinarians develop complex vaccination plans tailored to each business’s unique needs. Our process includes:

  1. Investigating local epidemiological conditions and upcoming risks
  2. Reviewing the business’s current and past disease challenges
  3. Understanding specific goals for health, performance, and operational efficiency

Establishing an immune foundation at the hatchery

We believe a successful poultry vaccination program starts with establishing a strong immune foundation. When the immune system is compromised, chickens can’t protect themselves against many diseases; have poor immune response to administered vaccines; and subsequently experience poor growth and performance.

So our Veterinary Services team designs vaccination plans using VAXXITEK® HVT + IBD as the starting point, because it aids in the prevention of two of the biggest immune threats in chickens: infectious bursal disease (IBD) and Marek’s disease, and their consequences on the immune system.

Through hatchery administration of VAXXITEK HVT + IBD, this important protection is established early* in the birds’ lives, laying a strong foundation for flock health.5-8, 13-15, 31

Developing strategic vaccination solutions

Hatchery vaccination is becoming an industry standard, as a way of establishing early protection in a well-controlled environment, reducing labor on the farm, and minimizing stress on growing chickens.

Yet determining the right combination of hatchery vaccines (and which should be saved for field administration) can be a challenge. For instance, concurrent use of some vaccines could result in adverse interactions, which can reduce vaccine efficacy.

So talk to our Veterinary Services team about a strategic approach for your operation. Leveraging our deep expertise in avian science, we’ll create a solution that accounts for your most urgent disease priorities, an appropriate portfolio of vaccines, and the most suitable modes of administration.

Interesting in discussing a customized program for your business? Talk to your Boehringer Ingelheim representative or contact us.

Partners in creating strategic, comprehensive vaccination plans tailored to each business's specific health and productivity goals...

Read More

Referenced Publications

View all

1. Fernandez R, Rojo F, Garcia H, Sanchez P, Martinez H, Menendez A, Ruiz H et al. Field efficacy in broiler chickens in Latin America of vHVT-013, a Marek’s HVT vector vaccine expressing VP2 in infectious bursal disease virus. Oral presentation and abstract at the 15th congress of the World Veterinary Poultry Association, 2007; p199.

2. Atienza JC, Nagera AJ, Martinez PO, Baysac ND, Castillo MT, Damaso VR, Lemière S. Evaluation of a herpesvirus of turkey vector vaccine inducing protection against infectious bursal and Marek’s diseases (VAXXITEK® HVT+IBD) under Philippines field conditions. Oral presentation. XXIII World Poultry Congress, Brisbane, Australia. 2008. Article wpc0801684, 9 p.

3. Garritty AT. The eff ect of vectored HVT+IBD (Vaxxitek® HVT + IBD) vaccination on body weights, uniformity and virus shedding in commercial broilers. Abstract. International Poultry Scientifi c Forum, Atlanta, 2011; p31.

4. Godinho E, Pereira CJ, Fernandez A, Lemiere S. Case study of broiler chicken carcass condemnation in Brazil – Improved control using a herpesvirus turkey-infectious bursal disease (HVT-IBD) vector vaccine. Oral presentation. XVIIth Congress of the World Veterinary Poultry Association, Cancun, Mexico, 2011.

5. Hoerr FJ. Clinical Aspects of Immunosuppression in Poultry. Avian Dis., 2010; 54:2-15.

6. Naqi S, Thompson G, Bauman B, Mohammed H. The Exacerbating Effect of Infectious Bronchitis Virus Infection on the Infectious Bursal Disease Virus-Induced Suppression of Opsonization by Escherichia coli Antibody in Chickens. Avian Dis., 2001; 45:52-60.

7. Alonso Castro M, Merino Cabria D, Fernandez Garcia D, Torrubia Diaz J, Herreras Viejo R, Fernandez Revuelta J, Mateo Oyague J, Carvajal Uruena A. Evaluation of the effects of vaccination with a HVT-IBD vector vaccine on bursa Fabricii, production parameters and meat properties in broilers. Abstract. XVIIIth Congress of the World Veterinary Poultry Association, Nantes, France, 2013; in-press.

8. Devaud I, Herin JB, Trotel A, Pagot E, Voisin F. A field study in commercial layers to evaluate the effects of an HVT-IBD vector vaccine on production performances in comparison with a live IBD vaccine. Abstract. XVIIIth Congress of the World Veterinary Poultry Association, Nantes, France, 2013; in-press.

9. Lemiere S, Gauthier J.C., Kodjo A., Vinit L., Delvecchio A., Prandini F. Evaluation of the Protection against Infectious Bursal Disease (IBD) Challenge in Progeny Born to Parents Having Received a Vaccination Program Using Herpesvirus of Turkey-Infectious Bursal Disease (HVT-IBD) Vector Vaccine. World J. Vaccines, 2013; 3:46-51.

10. Goutebroze S, Curet M, Jay ML, Roux C, Le Gros F-X. Efficacy of a recombinant vaccine HVT-VP2 against Gumboro disease in the presence of maternal antibodies. British Poultry Science, 2003;44:824-825.

11. Massi P, Tosi G, Fiorentini L. Experimental challenge trial with a «very virulent» strain of Infectious Bursal Disease virus (vvIBDV) in commercial pullets vaccinated with an IBD vectored vaccine or with three different modified live vaccines. Zootecnica International, November 2008;50-57.

12. Bublot M, Pritchard N, Le Gros F-X, Goutebroze S. Use of a vectored vaccine against infectious bursal disease of chickens in the face of high-titred maternally derived antibody. Journal of Comparative Pathology, 2007;137:81-84.

13. Ganapathy K, Wilkins M, Forrester A, Jones RC, Lemiere S. Protection and immune responses against virulent infectious bronchitis viruses in HVT-IBD recombinant or IBD-complex vaccinated broiler chicks. Abstract. 1st International Respiratory Disease Conference, Athens, United States of America, 2011; p15.

14. Lemiere S, Wilkins M, Forrester A, Jones R, Ganapathy K. Protection and immune responses against virulent infectious bronchitis (IB) viruses in herpesvirus turkey-infectious bursal disease (HVT-IBD) vaccinated broiler chicks. Poster presentation. XVIIth Congress of the World Veterinary Poultry Association, Cancun, Mexico, 2011.

15. Rautenschlein S, Lemiere S, Prandini F. Evaluation of the effects of an HVT-IBD vector vaccine on the immune system of layer pullets in comparison with two commercial live IBD vaccines. Abstract. XVIIIth Congress of the World Veterinary Poultry Association, Nantes, France, 2013; in-press.

16. Rosenberger JK, Cloud SS. Identification and characterization of variant infectious bursal disease variant viruses. Journal of American Veterinary Medicine Association, 1986;189:357.

17. Cheville NF. Studies on the pathogenesis of Gumboro disease in the bursa of Fabricius, spleen and thymus of the chicken. American Journal of Pathology, 1967;51:527-551.

18. Le Gros F-X, Dancer A, Giacomini C, Pizzoni L, Bublot M, Graziani M, Prandini F. Field efficacy trial of a novel HVT-IBD vector vaccine for 1 day-old broilers. Vaccine, 2009;27:592-596.

19. Prandini F, Bublot M, Le Gros F-X, Dancer A, Pizzoni L, Lamichhane C. Assessment of the immune response in broilers and pullets using two ELISA lits after in ovo or day-old vaccination with a vectored HVT+IBD vaccine (VAXXITEK HVT+IBD). Zootecnica International, September 2008;40-50.

20. Lemiere S, Wong YS, Saint-Gerand AL, Goutebroze S, le Gros FX. Compatibility of Turkey Herpesvirus–Infectious Bursal Disease Vector Vaccine with Marek’s Disease Rispens Vaccine Injected into Day-Old Pullets. Avian Dis., 2011; 55:113-118.

21. Richard-Mazet A, Goutebroze S, Duboeuf M, Le Gros FX, Lemiere S, Bublot M. Compatibility of fowlpox-avian influenza and herpesvirus of turkey-infectious bursal disease vector vaccines injected in ovo to embryonated chicken eggs. Article. XVIIth Congress of the World Veterinary Poultry Association, Cancun, Mexico, 2011; p852-857.

22. Jay ML, Bizzini S, Duboeuf M, Goutebroze S, Le-Gros FX. Compatibility of a novel vector vaccine HVT-Gumboro with Newcastle and infectious bronchitis vaccination at one day of age. Abstract. 16th congress of the World Veterinary Poultry Association, Marrakesh, Morocco, 2009; p341.

23. Lemiere S, Fernandez R, Pritchard N, Cruz-Coy J, Rojo F, Wong SY, Saint-Gerand AL, Gauthier JC, Perozo F. Concomitant Turkey Herpesvirus–Infectious Bursal Disease Vector Vaccine and Oil-Adjuvanted Inactivated Newcastle Disease Vaccine Administration: Consequences Compatibility of Turkey Herpesvirus–Infectious Bursal Disease. Avian Dis., 2011; 55:642-649.

24. Botero LA, Fernandez R, Rojo F, Orrego JC, Lemiere S. Colombian chicken meat industry performance further to the use of VAXXITEK HVT+IBD vector vaccine. Oral presentation. 16th congress of the World Veterinary Poultry Association, Marrakesh, Morocco, 2009; p169.

25. Körösi L, Povazsan J, Penzes L, Sari I. Field results of VAXXITEK HVT+IBD vaccination in coloured birds in Hungary. Poster. 16th congress of the World Veterinary Poultry Association, Marrakesh, Morocco, 2009; p339.

26. Tang SF, He SJ, Li WM, Lemiere S. Field experience of vaccination in day-old broiler chickens with a herpesvirus turkey-infectious bursal disease (HVT-IBD) vector vaccine in different systems of chicken production across China. Poster presentation. XVIIth Congress of the World Veterinary Poultry Association, Cancun, Mexico, 2011; p920-926.

27. Herrmann A, Negm H, Sultan H. Turkey herpesvirus infectious bursal disease (HVT-IBD) vector vaccine – Field experience in commercial broilers in Egypt. Article. XVIIth Congress of the World Veterinary Poultry Association, Cancun, Mexico, 2011; p556-563.

28. Ochoa R. Monitoring of safety and efficacy of a herpesvirus turkey-infectious bursal disease (HVT-IBD) in a commercial layer operation in Mexico. Article. XVIIth Congress of the World Veterinary Poultry Association, Cancun, Mexico, 2011; p770-774.

29. Korosi L, Povazsan J, Sari I, Penzes L. Comparative field study of the Vaxxitek® HVT-IBD vaccine in commercial layer flocks. Article. XVIIth Congress of the World Veterinary Poultry Association, Cancun, Mexico, 2011; p644-650.

30. Lemiere S, Rojo R, He S, Tang S, Li W, Herrmann A, Prandini F. Benefits of the Herpesvirus of Turkey vector vaccine of Infectious Bursal Disease in control of immune-depression in broilers and decrease of use of antibiotic medication. Abstract. XVIIIth Congress of the World Veterinary Poultry Association, Nantes, France, 2013; in-press.

31. Rautenschlein S, Lemiere S, Simon B, Prandini F. A comparison of the effects on the humoral and cell-mediated immunity between an HVT-IBD vector vaccine and an IBDV immune complex vaccine after in ovo vaccination of commercial broilers. Article. XVIIth Congress of the World Vet.

32. Lemiere S, Bublot M, de Saint-Vis B, Le-Gros FX, Dancer A, Bollart A, Carlotti A. Validation of VAXXITEK HVT+IBD vaccine intake in chickens using vHVT13-specifi c qPCR by processing different tissue samples. Oral presentation. 16th congress of the World Veterinary Poultry Association, Marrakesh, Morocco, 2009; p165.

33. Rautenschlein S, Simon B, Jung A, Pöppel M, Prandini F, Lemiere S. Protective efficacy of VAXXITEK HVT + IBD in commercial layers and broilers against challenge with very virulent infectious bursal disease virus. 16th congress of the World Veterinary Poultry Association, Marrakesh, Morocco, 2009.